Skip to main content
Top
Published in: Breast Cancer Research 6/2005

01-12-2005 | Editorial

Imaging in breast cancer – breast cancer imaging revisited

Author: David Mankoff

Published in: Breast Cancer Research | Issue 6/2005

Login to get access

Excerpt

In 2000, Breast Cancer Research published a series of articles describing the state-of-the-art of breast cancer imaging, edited by James Basilion [16]. This series reviewed developments in magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), radionuclide imaging with single-photon emission computed tomography (SPECT) and positron emission tomogrophy (PET), and optical imaging, including optical computed tomography and near infra-red imaging fluorescence. The series had an emphasis on technical development, pre-clinical research, and early clinical studies. Five years later, we revisit the same areas of breast cancer imaging with an eye towards ongoing translational research and new opportunities to detect breast cancer early and to direct effective, individualized therapy. …
Literature
1.
go back to reference Basilion JP: Current and future technologies for breast cancer imaging. Breast Cancer Res. 2001, 3: 14-16. 10.1186/bcr264.CrossRefPubMed Basilion JP: Current and future technologies for breast cancer imaging. Breast Cancer Res. 2001, 3: 14-16. 10.1186/bcr264.CrossRefPubMed
2.
go back to reference Berger F, Gambhir SS: Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer. Breast Cancer Res. 2001, 3: 28-35. 10.1186/bcr267.CrossRefPubMed Berger F, Gambhir SS: Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer. Breast Cancer Res. 2001, 3: 28-35. 10.1186/bcr267.CrossRefPubMed
3.
go back to reference Leach MO: Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res. 2001, 3: 22-27. 10.1186/bcr266.CrossRefPubMed Leach MO: Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res. 2001, 3: 22-27. 10.1186/bcr266.CrossRefPubMed
4.
go back to reference Ntziachristos V, Chance B: Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res. 2001, 3: 41-46. 10.1186/bcr269.CrossRefPubMed Ntziachristos V, Chance B: Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res. 2001, 3: 41-46. 10.1186/bcr269.CrossRefPubMed
5.
go back to reference Ronen SM, Leach MO: Imaging biochemistry: applications to breast cancer. Breast Cancer Res. 2001, 3: 36-40. 10.1186/bcr268.CrossRefPubMed Ronen SM, Leach MO: Imaging biochemistry: applications to breast cancer. Breast Cancer Res. 2001, 3: 36-40. 10.1186/bcr268.CrossRefPubMed
6.
go back to reference Schnall MD: Application of magnetic resonance imaging to early detection of breast cancer. Breast Cancer Res. 2001, 3: 17-21. 10.1186/bcr265.CrossRefPubMed Schnall MD: Application of magnetic resonance imaging to early detection of breast cancer. Breast Cancer Res. 2001, 3: 17-21. 10.1186/bcr265.CrossRefPubMed
8.
go back to reference Benard F, Turcotte E: Imaging breast cancer with signle photon computed tomography and positron emission tomography. Breast Cancer Res. 2005, 7: 153-162. 10.1186/bcr1201.CrossRefPubMedPubMedCentral Benard F, Turcotte E: Imaging breast cancer with signle photon computed tomography and positron emission tomography. Breast Cancer Res. 2005, 7: 153-162. 10.1186/bcr1201.CrossRefPubMedPubMedCentral
10.
go back to reference Tromberg BJ, Cerussi A, Shah N, Compton M, Fedyk A: Diffuse optics in breast cancer: detection in pre-menopausal women, co-registration with MRI, and monitoring neo-adjuvant chemotherapy. Breast Cancer Res. 2005, 7: 279-285.CrossRefPubMedPubMedCentral Tromberg BJ, Cerussi A, Shah N, Compton M, Fedyk A: Diffuse optics in breast cancer: detection in pre-menopausal women, co-registration with MRI, and monitoring neo-adjuvant chemotherapy. Breast Cancer Res. 2005, 7: 279-285.CrossRefPubMedPubMedCentral
11.
go back to reference Chen X, Moore MO, Lehman CD, Mankoff DA, Lawton TJ, Peacock S, Schubert EK, Livingston RB: Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. Acad Radiol. 2004, 11: 1115-1124. 10.1016/j.acra.2004.07.007.CrossRefPubMed Chen X, Moore MO, Lehman CD, Mankoff DA, Lawton TJ, Peacock S, Schubert EK, Livingston RB: Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. Acad Radiol. 2004, 11: 1115-1124. 10.1016/j.acra.2004.07.007.CrossRefPubMed
Metadata
Title
Imaging in breast cancer – breast cancer imaging revisited
Author
David Mankoff
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 6/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1359

Other articles of this Issue 6/2005

Breast Cancer Research 6/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine